Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights:
Speakers:
Greg Rotz, Pharmaceutical & Life Sciences Leader,PwC
Glenn Hunzinger, Health Industries Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
Next in pharma 2025: The future is now
Pharmaceutical and life sciences: US Deals 2025 outlook
President Donald J. Trump’s healthcare agenda
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.